TrialPloS one2010

Qualitative immune modulation by interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patients.

Francesca Sabbatini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.